Literature DB >> 12679914

Experimental study on ultrasound-guided intratumoral injection of "Star-99" in treatment of hepatocellular carcinoma of nude mice.

Li-Wu Lin1, Xiao-Dong Lin, Yi-Mi He, Shang-Da Gao, En-Sheng Xue.   

Abstract

AIM: To investigate the anti-cancer effect and the immunological mechanism of ultrasound-guided intratumoral injection of Chinese medicine "Star-99" in hepatocellular carcinoma (HCC) of nude mice.
METHODS: Twenty-eight human hepatocellular carcinoma SMMC-7721 transplanted nude mice, 14 of hypodermically implanted and 14 of orthotopic liver transplanted, were randomly divided into three groups of which 14 mice with Star-99, and 7 with ethanol and saline respectively. Ten days after the transplantation the medicines were injected into the tumors of all the nude mice once every 5 days. After 4 injections the nude mice were killed. The diameters of three dimension of the tumors were measured by high frequency ultrasound before and after the treatment and the tumor growth indexes(*) (TGI) were calculated. Radioimmunoassay was used to detect the serum levels of interleukin-2 (IL-2) and tumor necrosis factor (TNF)-alpha. The tumor tissues were sent for flow cytometry (FCM) DNA analysis. Apoptotic cells were visualized by TUNEL assay. All the experiments were carried out by double blind method.
RESULTS: The TGI of Star-99 group (0.076+/-0.024) was markedly lower than that of the saline group (4.654+/-1.283)(P<0.01). It also seemed to be lower than that of the ethanol group (0.082+/-0.028), but not significantly different (P>0.05). Serum levels of IL-2 and TNF-alpha were markedly higher than those of ethanol group and saline groups (P<0.05). The mean apoptotic index (AI: percentage of TUNEL signal positive cells) in Star-99 group (48.98+/-5.09 %) was significantly higher than that of the ethanol group (11.95+/-2.24 %) and the saline group (10.48+/-3.85 %) (P<0.01). FCM DNA analysis showed that the appearance rate of the apoptosis peak in Srar-99 group was 92.9 %, markedly higher than that of the ethanol group (14.3 %) and the saline group (0.0 %) (P<0.01). Correlation (r=0.499, P<0.05) was found between AI and serum level of TNF-alpha.
CONCLUSION: Star-99 has an effect on the elevation of the serum levels of IL-2 and TNF-alpha. It indicates that Star-99 has the function of enhancing the cellular immunity and inducing cancer cell apoptosis. The correlation between AI and serum level of TNF-alpha indicates that the elevation of the serum of TNF-alpha induced by Star-99 may be an important factor in the promotion of the hepatic cancer cell apoptosis. Star-99 has strong effects on the inhibition and destruction of cancer cells. Its curative effect is as good as ethanol. Its major mechanisms can be as follows: (1) it increases the serum levels of IL-2 and TNF-alpha and triggers cellular immunity. (2) It can induce cancer cells apoptosis, the effective mechanism of the Star-99 is different from that of the ethanol. The mechanisms of triggering the immunologic function of the organism and inducing cell apoptosis are, of particular significance. This study will provide a new pathway of drug administration and an experimental basis for the treatment of HCC with Chinese herbal, and the study of Star-99 in the treatment of tumor is of profound significance with good prospects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679914      PMCID: PMC4611432          DOI: 10.3748/wjg.v9.i4.701

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Determination of the optimal delay between sonications during focused ultrasound surgery in rabbits by using MR imaging to monitor thermal buildup in vivo.

Authors:  N J McDannold; F A Jolesz; K H Hynynen
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

2.  Apoptosis induced by norcantharidin in human tumor cells.

Authors:  Zhen-Xiao Sun; Qing-Wen Ma; Tian-De Zhao; Yu-Lin Wei; Guang-Sheng Wang; Jia-Shi Li
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

Review 3.  Ablative therapy for liver tumours.

Authors:  E A Dick; S D Taylor-Robinson; H C Thomas; W M W Gedroyc
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 4.  Prognostic prediction and treatment strategy in hepatocellular carcinoma.

Authors:  Jordi Bruix; Josep M Llovet
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

5.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

6.  Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients.

Authors:  C M Pacella; G Bizzarri; F Magnolfi; P Cecconi; B Caspani; V Anelli; A Bianchini; D Valle; S Pacella; G Manenti; Z Rossi
Journal:  Radiology       Date:  2001-12       Impact factor: 11.105

7.  Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

Authors:  T Livraghi; S N Goldberg; S Lazzaroni; F Meloni; T Ierace; L Solbiati; G S Gazelle
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

8.  Regulatory effect and mechanism of gastrin and its antagonists on colorectal carcinoma.

Authors:  Shuang-Wu He; Kang-Qiang Shen; Yu-Jun He; Bin Xie; Yan-Ming Zhao
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

9.  Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods.

Authors:  Manabu Morimoto; Kazuya Sugimori; Kazuhito Shirato; Atsushi Kokawa; Naohiko Tomita; Takafumi Saito; Noriko Tanaka; Akinori Nozawa; Masamichi Hara; Hisahiko Sekihara; Hiroshi Shimada; Toshio Imada; Katsuaki Tanaka
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

10.  Percutaneous microwave tumor coagulation for hepatocellular carcinomas with interruption of segmental hepatic blood flow.

Authors:  Takeshi Ishida; Takamichi Murakami; Takashi Shibata; Yutaka Inoue; Manabu Takamura; Takahiro Niinobu; Tadayuki Sato; Hironobu Nakamura
Journal:  J Vasc Interv Radiol       Date:  2002-02       Impact factor: 3.464

View more
  2 in total

1.  Anti-tumorigenic and Pro-apoptotic effects of CKBM on gastric cancer growth in nude mice.

Authors:  Vivian Yvonne Shin; Wallace Hau-Leung So; Edgar Shiu-Lam Liu; Ying-Jye Wu; Shiu-Fun Pang; Chi-Hin Cho
Journal:  Int J Med Sci       Date:  2004-08-05       Impact factor: 3.738

2.  Routes of delivery for CpG and anti-CD137 for the treatment of orthotopic kidney tumors in mice.

Authors:  Jennifer A Westwood; Titaina C U Potdevin Hunnam; Hollie J Pegram; Rodney J Hicks; Phillip K Darcy; Michael H Kershaw
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.